Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

From rising tariffs and stricter regulations to the increasing complexity of global sourcing, pharmaceutical importers are ...

Pharmexcil and Mexican Consulate join hands to chart new avenues for Indian pharma expansion: Shardul Nautiyal, Mumbai Tuesday, August 12, 2025, 08:00 Hrs [IST] In a bid to unlock ...

As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.

BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...

The regulatory environment is placing extreme pricing pressure on pharmaceutical manufacturers. Their success in the market ...